Torrent Pharma to Acquire JB Chemicals in ₹25,689 Crore Deal

Gujarat-based pharmaceutical major Torrent Pharmaceuticals has entered into definitive agreements with global investment firm KKR to acquire a controlling stake in JB Chemicals and Pharmaceuticals (JB Pharma) at an equity valuation of ₹25,689 crore on a fully diluted basis. The deal will be executed in phases, starting with the acquisition of a 46.39% stake for ₹11,917 crore , followed by a full merger of the two entities. This strategic move aligns with Torrent’s vision to build a future-ready, diversified healthcare platform , combining its strong domestic presence in chronic care with JB Pharma’s growing Indian business and international CDMO (Contract Development and Manufacturing Organization) capabilities. The transaction is expected to significantly enhance Torrent’s revenue and profitability while strengthening its position in both the Indian and global markets. KKR, which had previously invested in and transformed JB Pharma, expressed satisfaction with the company’s growth under its ownership and looks forward to a successful transition. With this acquisition, Torrent aims to expand its footprint in high-growth therapeutic areas and solidify its status as a leading player in the global pharma landscape.